Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis

Journal of Reproductive Immunology

Volumn 117, Issue , 2016, Pages 30-38

  Grandi, Giovanni ^a   Mueller, Michael D ^b,c   Papadia, Andrea ^b   Kocbek, Vida ^c   Bersinger, Nick A ^b,c   Petraglia, Felice ^d   Cagnacci, Angelo ^a   McKinnon, Brett ^b,c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF SIENA   (Italy)

Author keywords

Androgen receptor; Endometriosis; Glucocorticoid receptor; Inflammation; Membrane progesterone receptor; Mineralocorticoid receptor; Progesterone receptor; Progestin

Indexed keywords

ANDROGEN RECEPTOR; GESTAGEN; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 1BETA; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; STEROID RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; PROGESTERONE RECEPTOR; SEX HORMONE; TUMOR NECROSIS FACTOR;

ADULT; AGE; ARTICLE; CANCER HORMONE THERAPY; CELL ISOLATION; DISEASE COURSE; ENDOMETRIAL STROMAL CELL; ENDOMETRIOSIS; ENDOMETRIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; PERITONEAL FLUID; PRIORITY JOURNAL; RNA EXTRACTION; STROMA CELL; WESTERN BLOTTING; ADOLESCENT; CELL CULTURE; ENDOMETRIUM; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; PREGNANCY; TUMOR MICROENVIRONMENT; YOUNG ADULT;

ADOLESCENT; ADULT; CELLS, CULTURED; CELLULAR MICROENVIRONMENT; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; GONADAL STEROID HORMONES; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; PREGNANCY; PROGESTINS; RECEPTORS, GLUCOCORTICOID; RECEPTORS, PROGESTERONE; STROMAL CELLS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84976529623     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2016.06.004     Document Type: Article

References (37)

1. Attia, G.R., Zeitoun, K., Edwards, D., Johns, A., Carr, B.R., Bulun, S.E., Progesterone receptor isoform A but not B is expressed in endometriosis. J. Clin. Endocrinol. Metab. 85 (2000), 2897–2902.
2. Bamberger, A.M., Milde-Langosch, K., Löning, T., Bamberger, C.M., The glucocorticoid receptor is specifically expressed in the stromal compartment of the human endometrium. J. Clin. Endocrinol. Metab. 86 (2001), 5071–5074.
3. Bergqvist, A., Ferno, M., Oestrogen and progesterone receptors in endometriotic tissue and endometrium: comparison of different cycle phases and ages. Hum. Reprod. 8 (1993), 2211–2217.
4. Bersinger, N.A., Frischknecht, F., Taylor, R.N., Mueller, M.D., Basal and cytokine-stimulated production of epithelial neutrophil activating peptide-78 (ENA-78) and interleukin-8 (IL-8) by cultured human endometrial epithelial and stromal cells. Fertil. Steril. 89 (2008), 1530–1536.
5. Bersinger, N.A., Günthert, A.R., McKinnon, B., Johann, S., Mueller, M.D., Dose-response effect of interleukin (IL)-1β, tumour necrosis factor (TNF)-α, and interferon-γ on the in vitro production of epithelial neutrophil activating peptide-78 (ENA-78), IL-8, and IL-6 by human endometrial stromal cells. Arch. Gynecol. Obstet. 283 (2011), 1291–1296.
6. Bukulmez, O., Hardy, D.B., Carr, B.R., Word, R.A., Mendelson, C.R., Inflammatory status influences aromatase and steroid receptor expression in endometriosis. Endocrinology 149 (2008), 1190–1204.
7. Bunch, K., Tinnemore, D., Huff, S., Hoffer, Z.S., Burney, R.O., Stallings, J.D., Expression patterns of progesterone receptor membrane components 1 and 2 in endometria from women with and without endometriosis. Reprod. Sci. 21 (2014), 190–197.
8. Burney, R.O., Giudice, L.C., Pathogenesis and pathophysiology of endometriosis. Fertil. Steril. 98 (2012), 511–519.
9. Burney, R.O., Talbi, S., Hamilton, A.E., Vo, K.C., Nyegaard, M., Nezhat, C.R., Lessey, B.A., Giudice, L.C., Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology 148 (2007), 3814–3826.
10. Carneiro, M.M., Morsch, D.M., Camargos, A.F., Reis, F.M., Spritzer, P.M., Androgen receptor and 5alpha-reductase are expressed in pelvic endometriosis. BJOG 115 (2008), 113–117.
11. Chapman, K.E., Coutinho, A.E., Gray, M., Gilmour, J.S., Savill, J.S., Seckl, J.R., The role and regulation of 11beta-hydroxysteroid dehydrogenase type 1 in the inflammatory response. Mol. Cell. Endocrinol. 301 (2009), 123–131.
12. Cheng, Y.H., Imir, A., Fenkci, V., Yilmaz, M.B., Bulun, S.E., Stromal cells of endometriosis fail to produce paracrine factors that induce epithelial 17beta-hydroxysteroid dehydrogenase type 2 gene and its transcriptional regulator Sp1: a mechanism for defective estradiol metabolism. Am. J. Obstet. Gynecol. 196 (2007), 391e1–391e8.
13. Dunselman, G.A., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D'Hooghe, T., De Bie, B., Heikinheimo, O., Horne, A.W., Kiesel, L., Nap, A., Prentice, A., Saridogan, E., Soriano, D., Nelen, W., European Society of Human Reproduction and Embryology, ESHRE guideline: management of women with endometriosis. Hum Reprod. 29 (2014), 400–412.
14. de Ziegler, D., Borghese, B., Chapron, C., Endometriosis and infertility: pathophysiology and management. Lancet 376 (2010), 730–738.
15. Faresse, N., Post-translational modifications of the mineralocorticoid receptor: how to dress the receptor according to the circumstances?. J Steroid. Biochem. Mol. Biol. 143 (2014), 334–342.
16. Giudice, L.C., Kao, L.C., Endometriosis. Lancet 364 (2004), 1789–1799.
17. Grandi, G., Mueller, M.D., Bersinger, N., Cagnacci, A., Volpe, A., McKinnon, B., Does dienogest influence the inflammatory micro-environment of endometriotic lesions? A systematic review. Inflamm. Res. 65 (2016), 183–192.
18. Guo, S.-W., Nuclear factor-kappab (NF-kappaB): an unsuspected major culprit in the pathogenesis of endometriosis that is still at large?. Gynecol. Obstet. Invest. 63 (2007), 71–97.
19. Halme, J., Becker, S., Hammond, M.G., Raj, M.H., Raj, S., Increased activation of pelvic macrophages in infertile women with mild endometriosis. Am. J. Obstet. Gynecol. 145 (1983), 333–337.
20. Hornung, D., Bentzien, F., Wallwiener, D., Kiesel, L., Taylor, R.N., Chemokine bioactivity of RANTES in endometriotic and normal endometrial stromal cells and peritoneal fluid. Mol. Hum. Reprod. 7 (2001), 163–168.
21. Jones, R.K., Bulmer, J.N., Searle, R.F., Immunohistochemical characterization of proliferation, oestrogen receptor and progesterone receptor expression in endometriosis: comparison of eutopic and ectopic endometrium with normal cycling endometrium. Hum. Reprod. 10 (1995), 3272–3279.
22. Kowalik, M.K., Rekawiecki, R., Kotwica, J., The putative roles of nuclear and membrane-bound progesterone receptors in the female reproductive tract. Reprod. Biol. 13 (2013), 279–289.
23. McKinnon, B., Bersinger, N.A., Wotzkow, C., Mueller, M.D., Endometriosis-associated nerve fibers, peritoneal fluid cytokine concentrations, and pain in endometriotic lesions from different locations. Fertil. Steril. 97 (2012), 373–380.
24. McKinnon, B.D., Evers, J., Bersinger, N.A., Mueller, M.D., Induction of the neurokinin 1 receptor by TNFα in endometriotic tissue provides the potential for neurogenic control over endometriotic lesion growth. J. Clin. Endocrinol. Metab. 98 (2013), 2469–2477.
25. McKinnon, B.D., Bertschi, D., Bersinger, N.A., Mueller, M.D., Inflammation and nerve fiber interaction in endometriotic pain. Trends Endocrinol. Metab. 26 (2015), 1–10.
26. Monsivais, D., Bray, J.D., Su, E., Pavone, M.E., Dyson, M.T., Navarro, A., et al. Activated glucocorticoid and eicosanoid pathways in endometriosis. Fertil. Steril. 98 (2012), 117–125.
27. Moutsatsou, P., Sekeris, C.E., Steroid receptors in the uterus: implications in endometriosis. Ann. N. Y. Acad. Sci. 997 (2003), 209–222.
28. Practice Committee of American Society for Reproductive Medicine, Treatment of pelvic pain associated with endometriosis. Fertil. Steril. 90 (2008), S260–9.
29. Prentice, A., Randall, B.J., Weddell, A., McGill, A., Henry, L., Horne, C.H., Thomas, E.J., Ovarian steroid receptor expression in endometriosis and in two potential parent epithelia: endometrium and peritoneal mesothelium. Hum. Reprod. 7 (1992), 1318–1325.
30. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil. Steril. 67 (1997), 817–821.
31. Ruijter, J.M., Ramakers, C., Hoogaars, W.M.H., Karlen, Y., Bakker, O., van den Hoff, M.J.B., et al. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res., 37, 2009, e45.
32. Schindler, A.E., Campagnoli, C., Druckmannc, R., Huber, J., Pasqualini, J.R., Schweppe, K.W., Thijssen, J.H.H., Classification and pharmacology of progestins. Maturitas 61 (2008), 171–180.
33. Schliep, K.C., Mumford, S.L., Peterson, C.M., Chen, Z., Johnstone, E.B., Sharp, H.T., Stanford, J.B., Hammoud, A.O., Sun, L., Buck Louis, G.M., Pain typology and incident endometriosis. Hum. Reprod. 30 (2015), 2427–2438.
34. Schneider, C.A., Rasband, W.S., Eliceiri, K.W., NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9 (2012), 671–675.
35. Shao, R., Cao, S., Wang, X., Feng, Y., Billig, H., The elusive and controversial roles of estrogen and progesterone receptors in human endometriosis. Am. J. Transl. Res. 6 (2014), 104–113.
36. Stringer-Reasor, E.M., Baker, G.M., Skor, M.N., Kocherginsky, M., Lengyel, E., Fleming, G.F., Conzen, S.D., Glucocorticoid receptor activation inhibits chemotherapy-induced cell death in high-grade serous ovarian carcinoma. Gynecol. Oncol. 138 (2015), 656–662.
37. Vercellini, P., Fedele, L., Pietropaolo, G., Frontino, G., Somigliana, E., Crosignani, P.G., Progestogens for endometriosis: forward to the past. Hum. Reprod. Update 9 (2003), 387–396.